Natera, Inc. reported $2.71B of revenue over the trailing twelve months, +38% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.71B (to Q2 2026). Net Income: −$192M, trailing twelve months to Q2 2026. Free Cash Flow: $84M, trailing twelve months to Q2 2026. Op Margin: −11%, trailing twelve months to Q2 2026.

NTRANatera, Inc.

HealthcareUSD

$338.52

$151.9552 weeks$338.52

NTRA as reported

Natera, Inc. reported $2.71B of revenue over the trailing twelve months, +38% on the year before. 10 reported series are charted on this page, each one as filed.

$2.71B

Revenue, trailing twelve months · to Q2 2026 · +38% against the twelve months before

Net Income: −$192M
Net Income · −24% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $84M
Free Cash Flow · −19% year on year · trailing twelve months to Q2 2026
Op Margin: −11%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for NTRA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.71B	+38%	Q2 2026
Net Income	−$192M	−24%	Q2 2026
EPS	−$1.35	−29%	Q2 2026
Gross Margin	49%	n/a	Q2 2020 · 24 quarters behind
Op Margin	−11%	n/a	Q2 2026
Net Margin	−7.2%	n/a	Q2 2026
ROE	−15%	n/a	Q2 2026
ROA	−10%	n/a	Q2 2026
ROIC	−48%	n/a	Q2 2026
Free Cash Flow	$84M	−19%	Q2 2026